Neuro Vigor, a Purdue University-affiliated biotechnology company developing drugs that neutralize reactive aldehydes, announced Tuesday (Oct. 26) a collaboration agreement with the University of Western Australia to jointly develop proprietary drugs to initially target neurodegenerative diseases and pain in spinal cord injury, or SCI.